The Lymphoma Academic Research Organisation

This study tested a multi-step treatment plan for adults with a type of blood cancer called mantle cell lymphoma. The plan involved strong chemotherapy, a stem cell transplant using the patient's own cells, and then several years of ongoing maintenance therapy with a drug called …

This study tested whether adding the experimental drug pixantrone to three existing lymphoma medications could help control aggressive non-Hodgkin lymphoma that has returned or stopped responding to previous treatments. The trial involved 74 adults whose cancer had relapsed or wa…

This large, completed Phase 3 trial tested if a combination of the drugs lenalidomide and rituximab could better control follicular lymphoma—a slow-growing but hard-to-cure blood cancer—compared to the standard treatment of rituximab plus chemotherapy. It involved over 1,000 adul…

This study tested an experimental drug called glofitamab for patients with aggressive lymphomas whose cancer returned or didn't respond after CAR-T cell therapy. The trial enrolled 67 patients across two groups with different lymphoma types. Researchers aimed to see if this new a…